Orbis Allan Gray LtdOrbis Allan Gray Ltd

Institutional investor · Portfolio as of Q1 2019

Top Holdings57 positions

Checking export access…
Activity:
NTESNTES
ADR

NETEASE COM INC

10.6M$2.6B17.3%$41.270.00%
1 qtr
First report
0

ABBVIE INC

17.8M$1.4B9.7%$58.460.00%
1 qtr
First report
0
CELGCELGDelisted

CELGENE CORP

13.9M$1.3B8.9%——
1 qtr
First report
0

XPO INC

21.4M$1.2B7.8%$18.590.00%
1 qtr
First report
0
ATHMATHM
ADR

AUTOHOME INC

9.8M$1B7.0%$86.140.00%
1 qtr
First report
0

META PLATFORMS INC

4.5M$743.4M5.0%$165.530.00%
1 qtr
First report
0

ELEVANCE HEALTH INC FORMERLY

2M$561.2M3.8%$258.460.00%
1 qtr
First report
0
VALEVALE
ADR

VALE S A

42.8M$559.2M3.8%$6.840.00%
1 qtr
First report
0
stockAPACHE CORPDelisted
14.5M$502.3M3.4%$28.780.00%
1 qtr
First report
0

DOLLAR GEN CORP

3.9M$465.7M3.2%$108.540.00%
1 qtr
First report
0

ALPHABET INC

378,741$444.4M3.0%$58.120.00%
1 qtr
First report
0

SLB LIMITED

9.8M$427.3M2.9%$36.000.00%
1 qtr
First report
0
20.6M$394.6M2.7%$14.400.00%
1 qtr
First report
0

WELLS FARGO & CO

7.6M$365M2.5%$39.970.00%
1 qtr
First report
0

S&P GLOBAL INC

1.3M$282.6M1.9%$186.890.00%
1 qtr
First report
0
TSMTSM
ADR

TAIWAN SEMICONDUCTOR MANUFAC

6.3M$256.1M1.7%$34.760.00%
1 qtr
First report
0
ITUBITUB
Preferred

ITAU UNIBANCO HLDG S A

25M$220.5M1.5%$4.230.00%
1 qtr
First report
0

PEABODY ENGR CORP

7.5M$212.2M1.4%$26.660.00%
1 qtr
First report
0
BERYBERYDelisted

BERRY GLOBAL GROUP INC

3.8M$204.8M1.4%——
1 qtr
First report
0

GOLAR LNG LTD

9.3M$195.9M1.3%$18.710.00%
1 qtr
First report
0
$14.7B
AUM
57
Positions
Q1 2019
Filing
HI score · 3.0/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
Q1'19

First report: nothing earlier to compare

Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
<1Q100%1-4Q0%1-2Y0%2Y+0%

Orbis Allan Gray Ltd manages $14.7B across 57 positions as of Q1 2019. Top holdings: NTES (17.3%), ABBV (9.7%), CELG (8.9%). Fund DNA: Concentrated Value. HoldingsIntel Score: 3/5.0.

Q1 2019 Summary

First quarter we have for this fund: 57 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $14.7B across 57 positions.

Top holdings by portfolio weight

Total AUM$15B
NTES17.32%
ABBV9.73%
CELG8.89%
XPO7.81%
ATHM6.98%
META5.04%
ELV3.81%
VALE3.79%
APACHE CORP3.41%
DG3.16%
Other3.01%

Portfolio allocation by GICS sector

Sectors11
Communication Services32.81%
Healthcare14.74%
Unknown13.66%
Industrials11.11%
Energy10.59%
Financial Services6.13%
Basic Materials4.72%
Consumer Defensive3.29%
Technology1.76%
Consumer Cyclical0.71%
Other0.48%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Communication Services, Healthcare, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L56
Conviction47
Concentration60
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
FSVFSVFIRSTSERVICE CORP NEW
Q4 2024 → Q2 2026+3.6M shares+$486.7M
7Q
MCSMCSMARCUS CORP DEL
Q4 2024 → Q2 2026+1.1M shares+$34.9M
7Q
BURBURBURFORD CAPITAL LIMITED
Q4 2024 → Q2 2026+8.3M shares-$24.7M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used